BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12796025)

  • 1. Expression of KIT and epidermal growth factor receptor in chemotherapy refractory non-seminomatous germ-cell tumors.
    Madani A; Kemmer K; Sweeney C; Corless C; Ulbright T; Heinrich M; Einhorn L
    Ann Oncol; 2003 Jun; 14(6):873-80. PubMed ID: 12796025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancer.
    Kollmannsberger C; Mayer F; Pressler H; Koch S; Kanz L; Oosterhuis JW; Looijenga LH; Bokemeyer C
    Cancer; 2002 Jul; 95(2):301-8. PubMed ID: 12124830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of the c-kit gene in testicular germ cell tumors.
    Sakuma Y; Sakurai S; Oguni S; Hironaka M; Saito K
    Cancer Sci; 2003 Jun; 94(6):486-91. PubMed ID: 12824871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors.
    Moroni M; Veronese S; Schiavo R; Carminati O; Sorensen BS; Gambacorta M; Siena S
    Clin Cancer Res; 2001 Sep; 7(9):2770-5. PubMed ID: 11555591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of EGFR, HER-2/neu and KIT in germ cell tumours.
    Durán I; García-Velasco A; Ballestín C; García E; Martínez-Tello F; Pond GR; García-Carbonero R; Cortés-Funés H; Paz-Ares L
    Clin Transl Oncol; 2010 Jun; 12(6):443-9. PubMed ID: 20534400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor-beta expression in human testicular germ cell tumors.
    Pais V; Leav I; Lau KM; Jiang Z; Ho SM
    Clin Cancer Res; 2003 Oct; 9(12):4475-82. PubMed ID: 14555521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and diagnostic significance of OCT4, CD117 and CD30 in germ cell tumors].
    Teng LH; Lu DH; Xu QZ; Fu YJ; Yang H; He ZL
    Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):711-5. PubMed ID: 16536313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kit expression in male germ cell tumors.
    Nikolaou M; Valavanis C; Aravantinos G; Fountzilas G; Tamvakis N; Lekka I; Arapantoni-Dadioti P; Zizi A; Ghiconti I; Economopoulos T; Pectasides D
    Anticancer Res; 2007; 27(3B):1685-8. PubMed ID: 17595797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
    Yoh K; Nishiwaki Y; Ishii G; Goto K; Kubota K; Ohmatsu H; Niho S; Nagai K; Saijo N
    Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of HER-2/neu in testicular tumors.
    Mandoky L; Geczi L; Bodrogi I; Toth J; Bak M
    Anticancer Res; 2003; 23(4):3447-51. PubMed ID: 12926088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of the c-kit proto-oncogene in germ cell tumours.
    Izquierdo MA; Van der Valk P; Van Ark-Otte J; Rubio G; Germa-Lluch JR; Ueda R; Scheper RJ; Takahashi T; Giaccone G
    J Pathol; 1995 Nov; 177(3):253-8. PubMed ID: 8551387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial.
    Subbiah V; Meric-Bernstam F; Mills GB; Shaw KR; Bailey AM; Rao P; Ward JF; Pagliaro LC
    J Hematol Oncol; 2014 Aug; 7():52. PubMed ID: 25085632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of c-kit exons 11- and 17-activating mutations in testicular seminomas by high-resolution melting amplicon analysis.
    Willmore-Payne C; Holden JA; Chadwick BE; Layfield LJ
    Mod Pathol; 2006 Sep; 19(9):1164-9. PubMed ID: 16741525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor AP-2gamma, a novel marker of gonocytes and seminomatous germ cell tumors.
    Pauls K; Jäger R; Weber S; Wardelmann E; Koch A; Büttner R; Schorle H
    Int J Cancer; 2005 Jun; 115(3):470-7. PubMed ID: 15700319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors.
    Mata DA; Yang SR; Ferguson DC; Liu Y; Sharma R; Benhamida JK; Al-Ahmadie HA; Chakravarty D; Solit DB; Tickoo SK; Gupta S; Arcila ME; Ladanyi M; Feldman DR; Reuter VE; Vanderbilt CM
    Urology; 2020 Oct; 144():111-116. PubMed ID: 32721511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth regulatory factors and signalling proteins in testicular germ cell tumours.
    Devouassoux-Shisheboran M; Mauduit C; Tabone E; Droz JP; Benahmed M
    APMIS; 2003 Jan; 111(1):212-24; discussion 224. PubMed ID: 12752264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical and mutational analysis of the p53 tumour suppressor gene and the bcl-2 oncogene in primary testicular germ cell tumours.
    Heidenreich A; Schenkman NS; Sesterhenn IA; Mostofi KF; Moul JW; Srivastava S; Engelmann UH
    APMIS; 1998 Jan; 106(1):90-9; discussion 99-100. PubMed ID: 9524567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite instability of germ cell tumors is associated with resistance to systemic treatment.
    Mayer F; Gillis AJ; Dinjens W; Oosterhuis JW; Bokemeyer C; Looijenga LH
    Cancer Res; 2002 May; 62(10):2758-60. PubMed ID: 12019150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations and protein expression of KIT and PDGFRA genes in ipsilateral testicular seminomas: an immunohistochemical and molecular genetic study.
    Terada T
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):450-3. PubMed ID: 21403518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.